BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12151850)

  • 1. The paraoxonase gene family and coronary heart disease.
    Mackness B; Durrington PN; Mackness MI
    Curr Opin Lipidol; 2002 Aug; 13(4):357-62. PubMed ID: 12151850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase and coronary heart disease.
    Mackness MI; Mackness B; Durrington PN
    Atheroscler Suppl; 2002 Dec; 3(4):49-55. PubMed ID: 12573363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
    Mackness MI; Durrington PN; Mackness B
    Am J Cardiovasc Drugs; 2004; 4(4):211-7. PubMed ID: 15285696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
    Malin R; Knuuti J; Janatuinen T; Laaksonen R; Vesalainen R; Nuutila P; Jokela H; Laakso J; Jaakkola O; Solakivi T; Lehtimäki T
    J Mol Med (Berl); 2001 Aug; 79(8):449-58. PubMed ID: 11511975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase and atherosclerosis.
    Durrington PN; Mackness B; Mackness MI
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):473-80. PubMed ID: 11304460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase genes and disease.
    Hegele RA
    Ann Med; 1999 Jun; 31(3):217-24. PubMed ID: 10442677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?
    Heinecke JW; Lusis AJ
    Am J Hum Genet; 1998 Jan; 62(1):20-4. PubMed ID: 9443884
    [No Abstract]   [Full Text] [Related]  

  • 8. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice.
    Shih DM; Xia YR; Wang XP; Wang SS; Bourquard N; Fogelman AM; Lusis AJ; Reddy ST
    Circ Res; 2007 Apr; 100(8):1200-7. PubMed ID: 17379834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation.
    Mackness B; Durrington PN; Mackness MI
    Lancet; 1999 Feb; 353(9151):468-9. PubMed ID: 9989726
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
    Mackness M; Durrington P; Mackness B
    Curr Opin Lipidol; 2004 Aug; 15(4):399-404. PubMed ID: 15243212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum paraoxonase: a risk factor for atherosclerotic disease?
    Mackness MI; Durrington PN; Ayub A; Mackness B
    Chem Biol Interact; 1999 May; 119-120():389-97. PubMed ID: 10421475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
    Ruiz J; Blanché H; James RW; Garin MC; Vaisse C; Charpentier G; Cohen N; Morabia A; Passa P; Froguel P
    Lancet; 1995 Sep; 346(8979):869-72. PubMed ID: 7564671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids.
    Reddy ST; Wadleigh DJ; Grijalva V; Ng C; Hama S; Gangopadhyay A; Shih DM; Lusis AJ; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):542-7. PubMed ID: 11304470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
    Mackness M; Mackness B
    Free Radic Biol Med; 2004 Nov; 37(9):1317-23. PubMed ID: 15454272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.
    Mackness MI; Arrol S; Mackness B; Durrington PN
    Lancet; 1997 Mar; 349(9055):851-2. PubMed ID: 9121268
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraoxonase and coronary heart disease.
    Mackness MI; Mackness B; Durrington PN; Fogelman AM; Berliner J; Lusis AJ; Navab M; Shih D; Fonarow GC
    Curr Opin Lipidol; 1998 Aug; 9(4):319-24. PubMed ID: 9739487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
    Pfohl M; Koch M; Enderle MD; Kühn R; Füllhase J; Karsch KR; Häring HU
    Diabetes; 1999 Mar; 48(3):623-7. PubMed ID: 10078566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-gene paraoxonase family: physiologic roles, actions and regulation.
    Précourt LP; Amre D; Denis MC; Lavoie JC; Delvin E; Seidman E; Levy E
    Atherosclerosis; 2011 Jan; 214(1):20-36. PubMed ID: 20934178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human serum paraoxonase.
    Mackness B; Durrington PN; Mackness MI
    Gen Pharmacol; 1998 Sep; 31(3):329-36. PubMed ID: 9703197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins.
    Karakaya A; Ibiş S; Kural T; Köse SK; Karakaya AE
    Chem Biol Interact; 1999 Apr; 118(3):193-200. PubMed ID: 10362226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.